OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19
Patricia Mester, Pablo Amend, Stephan Schmid, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1511-1511
Open Access | Times Cited: 9

Showing 9 citing articles:

Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection
Khursheed Muzammil, Mohammad Hosseini Hooshiar, Shirin Varmazyar, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14

Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 9

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels
Patricia Mester, Pablo Amend, Stephan Schmid, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 4, pp. 593-607
Open Access | Times Cited: 3

Elevated plasma soluble lectin-like oxidised low-density lipoprotein receptor 1 as an independent prognostic biomarker in sepsis
Patricia Mester, Charlotte Birner, Stephan Schmid, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access

Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals
Amrita Shukla, Ankita Singh, Smriti Tripathi
Journal of the American Nutrition Association (2024) Vol. 43, Iss. 7, pp. 614-626
Closed Access | Times Cited: 2

A bibliometric analysis of PCSK9 inhibitors from 2007 to 2022
Qin Luo, Zhenchu Tang, Panyun Wu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4

Plasma Insulin-like Growth Factor-Binding Protein-2 of Critically Ill Patients Is Related to Disease Severity and Survival
Patricia Mester, U. Räth, Luisa Popp, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3285-3285
Open Access | Times Cited: 4

Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study
Yuanlu Shu, Ziwei Deng, Ye Deng, et al.
BMC Emergency Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Cholesterol and Cholesterol-Lowering Medications in COVID-19—An Unresolved Matter
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10489-10489
Open Access

Page 1

Scroll to top